Presentation NY Valves 2024 What’s Next? Managing the Disease and Advanced Training Presenter: Charles J. Davidson June 07, 2024
Presentation NY Valves 2024 Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show? Presenter: Javed Butler June 06, 2024
Presentation NY Valves 2024 Advances in Imaging for SHD: Icing on the Cake or True Need? Presenter: Scott M. Chadderdon June 06, 2024
Presentation NY Valves 2024 Current and Future use of Artificial Intelligence in Echocardiography Presenter: Akhil Narang June 05, 2024
Presentation NY Valves 2024 Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes Presenter: Madalina Garbi June 05, 2024
Presentation NY Valves 2024 Unleashing the Potential of CMR and CT: Myocardial Risk Stratification for VHD Presenter: Omar K. Khalique June 05, 2024
Presentation NY Valves 2024 Overview of the Role of Artificial Intelligence and Machine Learning for VHD Detection Presenter: Timothy Joseph Poterucha June 05, 2024
Presentation ACC 2024 Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk Presenter: Ronald Chi Hang Lee April 06, 2024
Presentation THT 2024 Cardiac Contractility Modulator as an Option for Advanced Heart Failure Patients Dependent on Low Dose inotropes Presenter: Kanika P. Mody March 06, 2024
Presentation THT 2024 Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling Presenter: Stavros G. Drakos March 05, 2024
Presentation THT Abstracts 2024 Use of EMR-Based Clinical Workflows Improves Access and Equity for Patients with Advanced Heart Failure 2013 A Single Center Experience March 05, 2024
Presentation THT 2024 How to Manage VT in Advanced HF and Post-LVAD Patients Presenter: Jakub Sroubek March 05, 2024
Presentation THT 2024 Patient Identification and Post-implant Management within an Advanced Heart Failure Program Presenter: Dmitry Yaranov March 05, 2024
Presentation THT 2024 A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1 Presenter: Lothar Roessig March 05, 2024
Presentation THT 2024 Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy Presenter: Daniel Asemota March 05, 2024
Presentation THT Abstracts 2024 Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock Presenter: McKenzie Sicke March 04, 2024
Presentation THT Abstracts 2024 Aortic Pulsatility Index does not predict use of temporary mechanical support among patients with Advanced Heart Failure Awaiting Cardiac Transplant. Presenter: Muhammad Saad March 04, 2024
Presentation THT Abstracts 2024 Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial Presenter: William Abraham March 04, 2024
Presentation THT 2024 Durrable LVADs: Innovations in Programming and Management Required to Advance the Field Presenter: Melana Yuzefpolskaya March 04, 2024